| Philip Randall Chapman, MD | |
|
619 19th Street South, Birmingham, AL 35249-1900 | |
| (205) 934-4011 | |
| Not Available |
| Full Name | Philip Randall Chapman |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 32 Years |
| Location | 619 19th Street South, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437175429 | NPI | - | NPPES |
| 009913899 | Medicaid | AL | |
| 051549108 | Other | AL | BCBS |
| 009913897 | Medicaid | AL | |
| 009913901 | Medicaid | AL | |
| 051546480 | Other | AL | BCBS |
| 051546481 | Other | AL | BCBS |
| P00608183 | Other | RAILROAD MEDICARE | |
| 051546482 | Other | AL | BCBS |
| 00118740 | Medicaid | MS | |
| 009913900 | Medicaid | AL | |
| 051546479 | Other | AL | BCBS |
| 101952 | Medicaid | AL |
| Facility Name | Location | Facility Type |
|---|---|---|
| Duke University Hospital | Durham, NC | Hospital |
| Duke Health Raleigh Hospital | Raleigh, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Duke Health Integrated Practice Inc | 8325412737 | 2551 |
News Archive
A study by researchers at the Transdisciplinary Tobacco Use Research Center of the University of Pennsylvania School of Medicine found that many smokers make false inferences about the safety of new low nicotine Quest cigarettes.
Although Democrats are having some success with attacks on the GOP Medicare plan, they are still playing defense on the health law, according to Politico. Meanwhile, former Office of Management and Budget Director Peter Orszag writes a "tell-all" for the magazine Foreign Affairs about the health overhaul.
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today announced that patients are being enrolled in a Phase 1 clinical trial evaluating IPI-493 in patients with advanced hematologic malignancies. This multi-center study is the second clinical trial of IPI-493, Infinity's oral heat shock protein 90 (Hsp90) chaperone inhibitor.
In current research related to improving cancer treatments, one promising area of research is the effort to find ways to selectively pinpoint and target cancer cells while minimizing effects on healthy cells.
New research on how cancer mutations influence a certain type of receptor on the cell membrane opens the way for the development of tailored drugs for certain cancers, such as rectal cancer and lung cancer.
› Verified 9 days ago
| Entity Name | Private Diagnostic Clinic Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457389033 PECOS PAC ID: 1355254368 Enrollment ID: O20031204000577 |
News Archive
A study by researchers at the Transdisciplinary Tobacco Use Research Center of the University of Pennsylvania School of Medicine found that many smokers make false inferences about the safety of new low nicotine Quest cigarettes.
Although Democrats are having some success with attacks on the GOP Medicare plan, they are still playing defense on the health law, according to Politico. Meanwhile, former Office of Management and Budget Director Peter Orszag writes a "tell-all" for the magazine Foreign Affairs about the health overhaul.
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today announced that patients are being enrolled in a Phase 1 clinical trial evaluating IPI-493 in patients with advanced hematologic malignancies. This multi-center study is the second clinical trial of IPI-493, Infinity's oral heat shock protein 90 (Hsp90) chaperone inhibitor.
In current research related to improving cancer treatments, one promising area of research is the effort to find ways to selectively pinpoint and target cancer cells while minimizing effects on healthy cells.
New research on how cancer mutations influence a certain type of receptor on the cell membrane opens the way for the development of tailored drugs for certain cancers, such as rectal cancer and lung cancer.
› Verified 9 days ago
| Entity Name | Duke Health Integrated Practice Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205553369 PECOS PAC ID: 8325412737 Enrollment ID: O20230327002247 |
News Archive
A study by researchers at the Transdisciplinary Tobacco Use Research Center of the University of Pennsylvania School of Medicine found that many smokers make false inferences about the safety of new low nicotine Quest cigarettes.
Although Democrats are having some success with attacks on the GOP Medicare plan, they are still playing defense on the health law, according to Politico. Meanwhile, former Office of Management and Budget Director Peter Orszag writes a "tell-all" for the magazine Foreign Affairs about the health overhaul.
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today announced that patients are being enrolled in a Phase 1 clinical trial evaluating IPI-493 in patients with advanced hematologic malignancies. This multi-center study is the second clinical trial of IPI-493, Infinity's oral heat shock protein 90 (Hsp90) chaperone inhibitor.
In current research related to improving cancer treatments, one promising area of research is the effort to find ways to selectively pinpoint and target cancer cells while minimizing effects on healthy cells.
New research on how cancer mutations influence a certain type of receptor on the cell membrane opens the way for the development of tailored drugs for certain cancers, such as rectal cancer and lung cancer.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Philip Randall Chapman, MD 500 22nd Street South, Suite 510 Finance, Birmingham, AL 35233-3110 Ph: (205) 731-9662 | Philip Randall Chapman, MD 619 19th Street South, Birmingham, AL 35249-1900 Ph: (205) 934-4011 |
News Archive
A study by researchers at the Transdisciplinary Tobacco Use Research Center of the University of Pennsylvania School of Medicine found that many smokers make false inferences about the safety of new low nicotine Quest cigarettes.
Although Democrats are having some success with attacks on the GOP Medicare plan, they are still playing defense on the health law, according to Politico. Meanwhile, former Office of Management and Budget Director Peter Orszag writes a "tell-all" for the magazine Foreign Affairs about the health overhaul.
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today announced that patients are being enrolled in a Phase 1 clinical trial evaluating IPI-493 in patients with advanced hematologic malignancies. This multi-center study is the second clinical trial of IPI-493, Infinity's oral heat shock protein 90 (Hsp90) chaperone inhibitor.
In current research related to improving cancer treatments, one promising area of research is the effort to find ways to selectively pinpoint and target cancer cells while minimizing effects on healthy cells.
New research on how cancer mutations influence a certain type of receptor on the cell membrane opens the way for the development of tailored drugs for certain cancers, such as rectal cancer and lung cancer.
› Verified 9 days ago
Dr. Garrett Colby, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 619 19th St S, Jt N342, Birmingham, AL 35249 Phone: 205-934-3108 Fax: 205-975-4413 | |
Drexell H Boggs, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1700 6th Ave S, Rm: 2253, Birmingham, AL 35233 Phone: 205-975-9399 Fax: 205-975-5184 | |
James Walker, Radiology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Joseph Smith, Radiology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Michelle M Mcnamara, MD Radiology Medicare: Medicare Enrolled Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-4011 | |
Sharda Mehar Bajaj, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1526 5th Ave S, Birmingham, AL 35233 Phone: 205-279-2860 | |
Gina Elizabeth Rebesco, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 625 19th St S, Birmingham, AL 35233 Phone: 205-975-0222 |